Genomic Health Posts Slight Increase in Q4 Revenues, Misses Wall Street Estimate | GenomeWeb

NEW YORK (GenomeWeb) ─ Genomic Health reported after the close of the market Tuesday that its fourth quarter revenues were up a fraction of 1 percent year over year, falling short of the consensus Wall Street estimate.

For the three months ended Dec. 31, Genomic Health had revenues of $69.1 million compared to $68.8 million in the same period last year. On average, analysts had expected revenues of $72 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.